![Lisa Jane Bright](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisa Jane Bright
Directeur/Membre du Conseil chez
ASCENDIS PHARMA A/S
Profil
Lisa Jane Bright is currently Chairman at Metadeq, Inc., Non-Executive Director at Dechra Pharmaceuticals Ltd. since 2019, Independent Director at Ascendis Pharma A since 2017, Director at Immedica Pharma AB, Advisor at DRI Healthcare, Executive Partner at Syncona Partners LLP, and President-International at Intercept Pharma Europe Ltd. since 2016.
Former roles include Chairman at Resolution Therapeutics Ltd., Vice President at Gilead Sciences, Inc., President-International at Intercept Pharmaceuticals, Inc. from 2016 to 2021, VP-Commercial Planning & Operations at GSK Plc from 1989 to 2006, General Manager at Gilead Sciences Ireland UC from 2008 to 2014, General Manager- UK & Ireland at Gilead Sciences Ltd. from 2008 to 2014, and Executive Partner at Syncona Ltd. Education includes undergraduate studies at University College London.
Postes actifs de Lisa Jane Bright
| Sociétés | Poste | Début |
|---|---|---|
| ASCENDIS PHARMA A/S | Directeur/Membre du Conseil | 01/04/2017 |
| DECHRA PHARMACEUTICALS | Directeur/Membre du Conseil | 01/02/2019 |
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Researches, develops and sells pharmaceutical products | Corporate Officer/Principal | 01/07/2016 |
DRI Healthcare
 DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Consultant / Advisor | - |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Consultant / Advisor | - |
Immedica Pharma AB
 Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops medicines for rare, genetic and metabolic diseases, hematology & oncology and specialty care | Directeur/Membre du Conseil | - |
Anciens postes connus de Lisa Jane Bright
| Sociétés | Poste | Fin |
|---|---|---|
Resolution Therapeutics Ltd.
 Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development in biotechnology | Président | 03/10/2024 |
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2021 |
Gilead Sciences Ireland UC
 Gilead Sciences Ireland UC Pharmaceuticals: MajorHealth Technology Engages in discover, develops and deliver innovative therapeutics for life-threatening diseases | Corporate Officer/Principal | 01/11/2014 |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Lisa Jane Bright
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
DRI Healthcare
DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Finance |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Syncona Ltd.
 Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Dechra Pharmaceuticals Ltd.
 Dechra Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells veterinary pharmaceuticals | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Immedica Pharma AB
Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops medicines for rare, genetic and metabolic diseases, hematology & oncology and specialty care | Health Technology |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
Gilead Sciences Ireland UC
Gilead Sciences Ireland UC Pharmaceuticals: MajorHealth Technology Engages in discover, develops and deliver innovative therapeutics for life-threatening diseases | Health Technology |
Gilead Sciences Ltd.
 Gilead Sciences Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Intercept Pharma Europe Ltd.
Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Researches, develops and sells pharmaceutical products | Commercial Services |
Resolution Therapeutics Ltd.
Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development in biotechnology | Commercial Services |
